Boston Partners
EW icon

Boston Partners’s Edwards Lifesciences EW Stock Holding History

Boston Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-819,600
Closed -$17.4M – 710
2014
Q4 		$17.4M Sell
819,600
-4,800
-0.6% -$96.4K 0.03% 322
2014
Q3 		$14M Hold
824,400
– – 0.02% 339
2014
Q2 		$11.8M Hold
824,400
– – 0.02% 365
2014
Q1 		$10.2M Buy
824,400
+554,868
+206% +$6.4M 0.02% 391
2013
Q4 		$2.95M Buy
+269,532
New +$3.04M 0.01% 581

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boston Partners's EW Position: Q1 2015 in Review

Boston Partners sold out of Edwards Lifesciences (EW) in Q1 2015, closing a stake of 819,600 shares — an estimated $17.4M sold.

Boston Partners first reported a position in EW in Q4 2013 and held it in 5 quarters. The position peaked at $17.4M in Q4 2014. 576 funds tracked by Wall St. Rank hold EW as of Q1 2015.

  • Boston Partners reported no remaining Edwards Lifesciences position as of Q1 2015 after selling out during the quarter.
  • Boston Partners sold 819,600 Edwards Lifesciences shares in Q1 2015, an estimated $17.4M.
  • Boston Partners first reported a position in Edwards Lifesciences in Q4 2013 and held it in 5 quarters.
  • Boston Partners's Edwards Lifesciences position peaked at $17.4M in Q4 2014.
  • 576 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2015.

Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.